^Clinical trial number NCT03694249 for "A Pilot Trial of Ifetroban, A Thromboxane A2 Receptor Antagonist, in Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence" at ClinicalTrials.gov
^Clinical trial number NCT03962855 for "The Thromboxane Receptor Antagonist to Blunt the Effects of Non-Platelet Thromboxane Generation and Improve Endothelial Cell Function (TRAP) Trial" at ClinicalTrials.gov
^Clinical trial number NCT02216357 for "A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease" at ClinicalTrials.gov
^Clinical trial number NCT03326063 for "Therapeutic Control of Aspirin-Exacerbated Respiratory Disease" at ClinicalTrials.gov
^Clinical trial number NCT03028350 for "A Phase 2 Multicenter, Double-blind, Randomized, Placebo-Controlled Trial to Evaluate Oral Ifetroban in Subjects With Symptomatic Aspirin Exacerbated Respiratory Disease (AERD)" at ClinicalTrials.gov
^Clinical trial number NCT02682511 for "A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients With Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension (SSc-PAH) " at ClinicalTrials.gov
^Clinical trial number NCT03340675 for "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study With an Open-Label Extension to Determine the Safety, Pharmacokinetics and Efficacy of Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy " at ClinicalTrials.gov
